Peripheral T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Peripheral T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL) [Phase 1]
A Phase 1 clinical trial is evaluating CCR4-directed CAR T cells in CCR4-expressing mature T-cell malignancies, including peripheral T-cell …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Circulating Tumor DNA Sequencing in Patients With Peripheral T-cell Lymphomas
This entry reports on a clinical trial investigating circulating tumor DNA sequencing in patients with peripheral T-cell lymphoma. The study…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study [Phase 2]
Phase II, single-center, single-arm clinical trial evaluating the safety and efficacy of golidocitinib in newly diagnosed peripheral T-cell …
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas [Phase 1, Phase 2]
A platform trial evaluating new drugs or drug combinations in relapsed/refractory peripheral T-cell lymphoma is currently recruiting for Pha…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma [Phase 2]
Phase IIa clinical trial update for Purinostat Mesylate for Injection in relapsed or refractory peripheral T-cell lymphoma and cutaneous T-c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma [Phase 2, Phase 3]
This document reports on an ongoing Phase 2/Phase 3 clinical trial evaluating cidabenamine plus azacitidine to prevent post-transplant progr…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma [Phase 1, Phase 2]
Clinical trial evaluating HH2853 for relapsed/refractory peripheral T-cell lymphoma is currently recruiting in Phase 1 and Phase 2.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Evaluate the Safety and Clinical Activity of HH2853 [Phase 1, Phase 2]
The trial update indicates HH2853 is being studied in Phase 1/Phase 2 across follicular lymphoma, epithelioid sarcoma, peripheral T-cell lym…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: A Study of Bosmolisib (BR101801) in Participants With R/R PTCL. [Phase 2]
Phase 2 trial update for Bosmolisib (BR101801) in relapsed/refractory Peripheral T cell lymphoma; the study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL [Phase 2]
Phase 2 clinical trial evaluating Zeprumetostat and Azacitidine in combination with Lipo-MIT for relapsed/refractory peripheral T-cell lymph…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers [Phase 1]
A Phase 1 safety study of PF-08046045/SGN-35T sponsored by Seagen has been terminated in adults with advanced lymphomas and Hodgkin disease.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL [Phase 2]
A randomized Phase II trial is comparing oral azacitidine plus romidepsin against investigator's choice in peripheral T-cell lymphoma and is…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR
ClinicalTrials.gov entry describes a recruiting study from Shanghai General Hospital investigating stratified therapy after complete respons…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma [Phase 2]
This clinical trial update describes a Phase 2 study evaluating SHR2554 as maintenance therapy for Peripheral T-cell lymphoma, with recruitm…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]
Results from a Phase 1/2 study of ALRN-6924 in patients with advanced solid tumors and lymphomas have been posted after completion of the tr…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma [Phase 3]
A Phase III randomized, double-blind multicenter study evaluating XNW5004 tablets in patients with relapsed or refractory peripheral T-cell …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma [Phase 3]
Phase 3 study of chidamide (SHR2554) for relapsed/refractory peripheral T-cell lymphoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 study evaluating ATG-010 in combination with chemotherapy with maintenance ATG-010 in Peripheral T-cell lymphoma and natural kil…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma [Phase 1, Phase 2]
Clinical trial update on a Phase 1/Phase 2 study of golidocitinib combined with mitoxantrone hydrochloride liposome or chidamide for relapse…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: AZD4205 in Relapsed or Refractory Peripheral T Cell Lymphoma (JACKPOT27) [Phase 2]
Clinical trial update indicates completion of the Phase 2 JACKPOT27 study of AZD4205 for relapsed or refractory peripheral T-cell lymphoma c…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)
A prospective, multicenter cohort study evaluating allogeneic versus autologous hematopoietic stem cell transplantation for peripheral T-cel…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies [Phase 1, Phase 2]
A Phase 1/2 study is evaluating CCS1477 (Inobrodib) in multiple hematologic malignancies and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL) [Phase 1, Phase 2]
This clinical trial update outlines a Phase 1/Phase 2 study evaluating the combination of liposomal mitoxantrone hydrochloride and Enlonstob…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Amping up With PemJAK [Phase 2]
A Phase 2 clinical trial of PemJAK for multiple lymphoma subtypes is currently recruiting, including non-Hodgkin lymphoma and Hodgkin lympho…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Golidocitinib Combined With GemOx in RR PTCL [Phase 2]
Phase 2 clinical trial update for golidocitinib in combination with GemOx for relapsed/refractory peripheral T-cell lymphoma; the trial is n…